Akech Samuel, Ayieko Philip, Gathara David, Agweyu Ambrose, Irimu Grace, Stepniewska Kasia, English Mike
Kenya Medical Research Institute/Wellcome Trust Research Programme, Nairobi, Kenya.
Department of Paediatrics and Child Health, University of Nairobi, Nairobi Kenya.
Lancet Child Adolesc Health. 2018 Jul;2(7):516-524. doi: 10.1016/S2352-4642(18)30130-5.
Diarrhoea causes many deaths in children younger than 5 years and identification of risk factors for death is considered a global priority. The effectiveness of currently recommended fluid management for dehydration in routine settings has also not been examined.
For this observational, association study, we analysed prospective clinical data on admission, immediate treatment, and discharge of children age 1-59 months with diarrhoea and dehydration, which were routinely collected from 13 Kenyan hospitals. We analysed participants with full datasets using multivariable mixed-effects logistic regression to assess risk factors for in-hospital death and effect of correct rehydration on early mortality (within 2 days).
Between Oct 1, 2013, and Dec 1, 2016, 8562 children with diarrhoea and dehydration were admitted to hospital and eligible for inclusion in this analysis. Overall mortality was 9% (759 of 8562 participants) and case fatality was directly correlated with severity. Most children (7184 [84%] of 8562) with diarrhoea and dehydration had at least one additional diagnosis (comorbidity). Age of 12 months or younger (adjusted odds ratio [AOR] 1·71, 95% CI 1·42-2·06), female sex (1·41, 1·19-1·66), diarrhoea duration of more than 14 days (2·10, 1·42-3·12), abnormal respiratory signs (3·62, 2·95-4·44), abnormal circulatory signs (2·29, 1·89-2·77), pallor (2·15, 1·76-2·62), use of intravenous fluid (proxy for severity; 1·68, 1·41-2·00), and abnormal neurological signs (3·07, 2·54-3·70) were independently associated with in-hospital mortality across hospitals. Signs of dehydration alone were not associated with in-hospital deaths (AOR 1·08, 0·87-1·35). Correct fluid prescription significantly reduced the risk of early mortality (within 2 days) in all subgroups: abnormal respiratory signs (AOR 1·23, 0·68-2·24), abnormal circulatory signs (0·95, 0·53-1·73), pallor (1·70, 0·95-3·02), dehydration signs only (1·50, 0·79-2·88), and abnormal neurological signs (0·86, 0·51-1·48).
Children at risk of in-hospital death are those with complex presentations rather than uncomplicated dehydration, and the prescription of recommended rehydration guidelines reduces risk of death. Strategies to optimise the delivery of recommended guidance should be accompanied by studies on the management of dehydration in children with comorbidities, the vulnerability of young girls, and the delivery of immediate care.
The Wellcome Trust.
腹泻导致许多5岁以下儿童死亡,确定死亡风险因素被视为全球优先事项。目前推荐的常规环境下脱水液体管理的有效性也尚未得到检验。
在这项观察性关联研究中,我们分析了从13家肯尼亚医院常规收集的1至59个月腹泻和脱水儿童入院、即时治疗及出院的前瞻性临床数据。我们使用多变量混合效应逻辑回归分析具有完整数据集的参与者,以评估院内死亡的风险因素以及正确补液对早期死亡率(2天内)的影响。
2013年10月1日至2016年12月1日期间,8562名腹泻和脱水儿童入院并符合纳入本分析的条件。总体死亡率为9%(8562名参与者中的759名),病死率与严重程度直接相关。大多数腹泻和脱水儿童(8562名中的7184名[84%])至少有一项额外诊断(合并症)。12个月及以下年龄(调整优势比[AOR]1.71,95%置信区间1.42 - 2.06)、女性(1.41,1.19 - 1.66)、腹泻持续时间超过14天(2.10,1.42 - 3.12)、呼吸体征异常(3.62,2.95 - 4.44)、循环体征异常(2.29,1.89 - 2.77)、面色苍白(2.15,1.76 - 2.62)、使用静脉输液(严重程度的替代指标;1.68,1.41 - 2.00)以及神经体征异常(3.07,2.54 - 3.70)在各医院中均与院内死亡率独立相关。仅脱水体征与院内死亡无关(AOR 1.08,0.87 - 1.35)。正确的补液处方在所有亚组中均显著降低了早期死亡率(2天内):呼吸体征异常(AOR 1.23,0.68 - 2.24)、循环体征异常(0.95,0.53 - 1.73)、面色苍白(1.70,0.95 - 3.02)、仅脱水体征(1.50,0.79 - 2.88)以及神经体征异常(0.86,0.51 - 1.48)。
有院内死亡风险的儿童是那些临床表现复杂的儿童,而非单纯性脱水儿童,推荐补液指南的处方可降低死亡风险。优化推荐指导实施的策略应伴随对合并症儿童脱水管理、年轻女孩的脆弱性以及即时护理提供情况的研究。
惠康信托基金会。